Covered recipient · General Payments record
SARANYA DINESAN
General Payments · PY2023–2024
$1,433.92
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,350.47 | 66 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $140.23 | 8 |
| Incyte Corporation | $133.32 | 7 |
| GENZYME CORPORATION | $108.40 | 6 |
| Celgene Corporation | $97.08 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $92.40 | 5 |
| Gilead Sciences, Inc. | $75.77 | 1 |
| Acerta Pharma LLC | $72.73 | 2 |
| PFIZER INC. | $70.29 | 4 |
| Merck Sharp & Dohme Corporation | $67.38 | 4 |
| SOBI, INC | $63.22 | 3 |
| Astellas Pharma US Inc | $60.30 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $59.33 | 3 |
| Alexion Pharmaceuticals, Inc. | $40.88 | 1 |
| E.R. Squibb & Sons, L.L.C. | $37.96 | 2 |
| ARRAY BIOPHARMA INC | $35.15 | 2 |
| Novo Nordisk AS | $23.14 | 1 |
| JAZZ PHARMACEUTICALS INC. | $21.03 | 1 |
| GlaxoSmithKline, LLC. | $20.13 | 1 |
| Genentech USA, Inc. | $18.02 | 1 |
| Janssen Pharmaceuticals, Inc | $18.01 | 1 |
| Lilly USA, LLC | $17.93 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $17.90 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.08 | 1 |
| Genmab U.S., Inc. | $15.98 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.34 | 1 |
| ABBVIE INC. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (66)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.